Migraine

A recent editorial outlined how to choose the necessary migraine pharmacotherapy for an elderly person and emphasized the importance of the careful personalization of treatment based on individual patient characteristics in order to choose a safe and effective migraine treatment.

According to a new study, prior migraine history is associated with brain tumors. While associated with both sexes, the risk is higher among men than women.

Patients who have migraine often suffer from coexisting issues, such as sleep difficulties, vertigo, and dizziness. A study evaluating the presence of certain symptoms in patients with migraine indicated that some may have a common pathophysiology.

Following treatment with either a lifestyle intervention or migraine education, patients with migraine had improved pain acceptance and lower migraine-related disability.

Researchers tested the hypothesis that a genetic risk score based on single-nucleotide polymorphisms may influence headache response to triptans in patients and found a significant relationship between triptan efficacy and the cumulative score of genetic risk.

This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.

Between 1999-2000 to 2014, the use of IV fluids, dopaminergic receptor antagonists prochlorperazine/metoclopramide, ketorolac, and dexamethasone increased while the use of narcotics decreased.

Many headache specialists are not satisfied with the care their patients receive in the emergency department (ED), demonstrating the need for more standardized protocols for ED visits by patients with known headache disorders, according to a new study.

Data from a post hoc analysis is adding to positive literature on vagus nerve stimulation, concluding that the treatment quickly and consistently reduced pain intensity while decreasing rescue medication use among patients with episodic migraine.

As migraine is significantly more prevalent in women than men—likely due to fluctuations in estrogen levels—researchers conducted a systematic review of data involving the effect of exogenous estrogens and progestogens on the course of migraine during reproductive age, resulting in recommendations for clinical decision making.

Following indications of an association between migraine and attention deficit and hyperactivity disorder (ADHD) in children and adolescents, a new study has demonstrated a significant comorbidity of the 2 conditions in adults.

Patients with insomnia had an increased risk of migraine and nonmigraine headache compared to those without insomnia.

A new study has indicated that long-term treatment with onabotulinumtoxin A is effective, safe, and well-tolerated in the patient population.

A review of migraine and cluster headache emphasizes how their shared pathophysiological pathways may be important for identifying future treatments.

UnitedHealthcare has announced it is listing 3 biosimilars as preferred drugs; Express Scripts has decided it will cover Eli Lilly’s and Amgen’s migraine drugs and will not cover Teva Pharmaceutical's drug; black men are more likely to get and die from prostate cancer compared with white men, but they are underrepresented in prostate cancer research because of a general distrust of the healthcare system.

Starting April 1, 2019, Express Scripts will offer its SafeGuardRx Migraine Care Value program, which will help patients achieve better outcomes with preventive therapies and offer a value-based design for plan sponsors.

In some instances, migraine can be treated without medicine, meaning some patients with migraine can cut down on their medication use, according to a new study that demonstrated efficacy with an inhaler that slightly changes the body’s own molecules.

Researchers compiled data from 2 studies demonstrating the safety and efficacy of erenumab at 4 weeks and found that the treatment resulted in a reduction of weekly migraine days as early as week 1.

Researchers developed a set of items based on a previous literature review and patients’ focus groups and tested it on a wide set of patients with episodic and chronic migraine.

The majority of patients who suffer from migraine experience premonitory symptoms and are able to predict at least 1 attack, according to a new study.

Researchers recently investigated what role exercise plays in migraine prevention and found that although exercise can trigger migraine attacks, regular exercise may have prophylactic effects on migraine frequency.

A study has found that noninvasive vagus nerve stimulation can provide pain relief for up to 60 minutes after an acute attack.